JPRN-UMIN000025358已完成未知
Quantitative Determination of Nadifloxacin in Follicles of Acne Patients Treated by Topical Nadifloxacin With or Without Adapalene and Benzoyl Peroxide - Measurement of the Level of Nadifloxacin in Follicles of Acne
Toshitatsu Nogita0 个研究点目标入组 30 人开始时间: 2016年12月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) The patient who had a following treatment within 4 weeks prior to the initiation of test drug treatment Facial chemical peering, Leaser therapy, or Phototherapy (2) The patient who had a following treatment within 2 weeks prior to the initiation of test drug treatment Use of Nadifloxacin on his/her face, Facial aesthetic treatment, Use of facial cleanser with scrub (3) The patient who would use or will not stop to use agent for skin (all of prescription medicine and OTC medicine) during the period of the study (4) Pregnant woman, might be pregnant woman, and/or Breastfeeding woman (5) The patient who is hypersensitivity to ingredients of test drug (6) The patient to whom physician recognize him/her will not be included in the study because of his/her history and complication of systemic diseases (7) The patient to who is participating other clinical research or study (8) The patient to whom physician judge as inappropriate for this clinical study due to safely issues
研究者
相似试验
进行中（未招募）
不适用
Determination of Moxifloxacin concentrations in interstitial space fluid of muscle and subcutis in septic patients including a pilot phaseTo evaluate feasibility of Moxifloxacin determination in septic patientsEUCTR2010-022150-16-ATMedizinische Universität Wien, Univ.Klinik f.klinische Pharmakologie
进行中（未招募）
1 期
Determining the tissue concentration of the antibiotic, dicloxacillin, using the Microdialysis technique (on healthy male subjects)EUCTR2014-000826-39-DKOrtopædkirurgisk afdeling Odense Universitetshospital
招募中
不适用
A clinical study of pazufloxacin administered at a dose of 1,000mg twice daily in patients with sepsis due to urogenital infectioSepsisJPRN-UMIN000010036PO CREC net100
进行中（未招募）
1 期
Population pharmacokinetics of levofloxacin in intensive care patients with severe community-acquired pneumonia - Lévo-PharmMedDRA version: 14.0 Level: LLT Classification code 10032502 Term: Other specified alveolar and parietoalveolar pneumopathies System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorderscommunity-acquired pneumoniaEUCTR2011-002177-34-FRCHU de Toulouse65
已完成
4 期
Dialyzabikity of levofloxacirenal failureJPRN-UMIN000004867Department of Nephrology, Tsukuba University Hospital10